Artikel mit Open-Access-Mandaten - Vânia Vilas-BoasWeitere Informationen
Nicht verfügbar: 3
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
R Silva, V Vilas-Boas, H Carmo, RJ Dinis-Oliveira, F Carvalho, ...
Pharmacology & therapeutics 149, 1-123, 2015
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Portable sensing system based on electrochemical impedance spectroscopy for the simultaneous quantification of free and total microcystin-LR in freshwaters
MB Dos Santos, RB Queirós, Á Geraldes, C Marques, V Vilas-Boas, ...
Biosensors and Bioelectronics 142, 111550, 2019
Mandate: European Commission, Government of Spain
Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models
V Vilas-Boas, M Vinken
Archives of toxicology 95 (1), 27-52, 2021
Mandate: Research Foundation (Flanders)
Verfügbar: 23
Green synthesis of fluorescent carbon dots from spices for in vitro imaging and tumour cell growth inhibition
N Vasimalai, V Vilas-Boas, J Gallo, M de Fátima Cerqueira, ...
Beilstein journal of nanotechnology 9 (1), 530-544, 2018
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Magnetic hyperthermia for cancer treatment: Main parameters affecting the outcome of in vitro and in vivo studies
V Vilas-Boas, F Carvalho, B Espiña
Molecules 25 (12), 2874, 2020
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Performance enhanced UV/vis spectroscopic microfluidic sensor for ascorbic acid quantification in human blood
H Bi, CM Duarte, M Brito, V Vilas-Boas, S Cardoso, P Freitas
Biosensors and Bioelectronics 85, 568-572, 2016
Mandate: Fundação para a Ciência e a Tecnologia, Portugal, European Commission
Mechanisms and in vitro models of drug-induced cholestasis
E Gijbels, V Vilas-Boas, N Deferm, L Devisscher, H Jaeschke, P Annaert, ...
Archives of toxicology 93, 1169-1186, 2019
Mandate: Research Foundation (Flanders), European Commission
Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies
R Silva, H Carmo, V Vilas-Boas, DJ Barbosa, A Palmeira, E Sousa, ...
Chemico-biological interactions 218, 50-62, 2014
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury
E Gijbels, V Vilas‐Boas, P Annaert, T Vanhaecke, L Devisscher, M Vinken
Archives of Toxicology 94, 1151-1172, 2020
Mandate: Research Foundation (Flanders)
Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
V Vilas-Boas, E Gijbels, J Jonckheer, E De Waele, M Vinken
Environment international 136, 105422, 2020
Mandate: Research Foundation (Flanders)
Primary hepatocytes and their cultures for the testing of drug-induced liver injury
V Vilas-Boas, A Cooreman, E Gijbels, R Van Campenhout, E Gustafson, ...
Advances in Pharmacology 85, 1-30, 2019
Mandate: Research Foundation (Flanders), European Commission
Nanosafety: an evolving concept to bring the safest possible nanomaterials to society and environment
F Lebre, N Chatterjee, S Costa, E Fernández-de-Gortari, C Lopes, ...
Nanomaterials 12 (11), 1810, 2022
Mandate: European Commission
Several transport systems contribute to the intestinal uptake of Paraquat, modulating its cytotoxic effects
R Silva, H Carmo, V Vilas-Boas, DJ Barbosa, M Monteiro, PG de Pinho, ...
Toxicology Letters 232 (1), 271-283, 2015
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Industrial, biocide, and cosmetic chemical inducers of cholestasis
V Vilas-Boas, E Gijbels, A Cooreman, R Van Campenhout, E Gustafson, ...
Chemical research in toxicology 32 (7), 1327-1334, 2019
Mandate: Research Foundation (Flanders), European Commission
RBE4 cells are highly resistant to paraquat‐induced cytotoxicity: studies on uptake and efflux mechanisms
V Vilas‐Boas, R Silva, P Guedes‐de‐Pinho, F Carvalho, ML Bastos, ...
Journal of Applied Toxicology 34 (9), 1023-1030, 2014
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Microfluidic-based skin-on-chip systems for safety assessment of nanomaterials
S Costa, V Vilas-Boas, F Lebre, JM Granjeiro, CM Catarino, LM Teixeira, ...
Trends in biotechnology 41 (10), 1282-1298, 2023
Mandate: European Commission
Primary human hepatocyte spheroids as tools to study the hepatotoxic potential of non-pharmaceutical chemicals
V Vilas-Boas, E Gijbels, K Leroy, A Pieters, A Baze, C Parmentier, ...
International journal of molecular sciences 22 (20), 11005, 2021
Mandate: Research Foundation (Flanders), European Commission
Effectiveness and safety of a nontargeted boost for a CXCR4-targeted magnetic hyperthermia treatment of cancer cells
V Vilas-Boas, B Espiña, YV Kolen’ko, M Bañobre-López, M Brito, ...
ACS Omega 4 (1), 1931-1940, 2019
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Combining CXCR4-targeted and nontargeted nanoparticles for effective unassisted in vitro magnetic hyperthermia
V Vilas-Boas, B Espina, YV Kolen'ko, M Banobre-Lopez, JA Duarte, ...
Biointerphases 13 (1), 2018
Mandate: Fundação para a Ciência e a Tecnologia, Portugal
Increased expression of adherens junction components in mouse liver following bile duct ligation
R Van Campenhout, S Crespo Yanguas, A Cooreman, E Gijbels, K Leroy, ...
Biomolecules 9 (10), 636, 2019
Mandate: Research Foundation (Flanders)
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt